Evidence map›Paper›PMID 37097000›Full record

ArticleAustralasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists2023

Could negative outcomes of psychotherapies be contributing to the lack of an overall population effect from the Australian Better Access initiative?

Stephen Allison, Jeffrey Cl Looi, Steve Kisely, Tarun Bastiampillai

Open access · hybridAbstract read
In one paragraph

Article in Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Stephen AllisonCollege of Medicine and Public Health, Flinders University of South Australia, Adelaide, SA, Australia; and.ORCID 0000-0002-9264-5310
Jeffrey Cl LooiAcademic Unit of Psychiatry and Addiction Medicine and Addiction Medicine, The Australian National University School of Medicine and Psychology, Canberra, ACT, Australia; and.ORCID 0000-0003-3351-6911
Steve KiselySchool of Medicine, University of Queensland, Woolloongabba, QLD, Australia.ORCID 0000-0003-4021-2924
Tarun BastiampillaiPsychiatry, Flinders University, Adelaide, SA, Australia; and.ORCID 0000-0002-6931-2913
Flinders University · AUAustralian National University · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe examine deterioration in psychotherapies, as reported in the recent evaluation of the Australian Medicare Better Access initiative.

conclusionA focus on patients who experience poor clinical outcomes helps programs minimise harm and improve quality of care. The Better Access evaluation found the mental health of 20-40% of patients deteriorated. This may partly explain why population distress and suicide rates were not reduced by the introduction of the Better Access initiative. Deterioration was more likely for milder conditions, and less likely for severe conditions, which also improved the most. Using severity as a criterion for priority setting and resource allocation may minimise patient risk and maximise benefits. Patients with severe conditions may require considerably more sessions than the current average for Better Access psychotherapies.

Indexed as

Mental HealthNational Health ProgramsAgedAustraliaHumansPsychotherapyAustralian Medicare Better Access initiativenegative effectsPsychotherapies

Identifiers

PMID37097000
PMCPMC10251454
OpenAlexW4366984959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.